drugset / Trial / NCT02538705
Safety and Efficacy Study of Neovasculgen (Pl-VEGF165) Gene Therapy in Patients With Diabetic Foot
Completed
35 enrolled
Artgen Biotech
Ryazan State Medical University · collabVidnoe District Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to determine whether pl-vegf165 (Neovasculgen) is effective in the treatment of ulcers related to diabetic foot syndrome
Timeline
- Start
- 2015-08
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Neovasculgen | Other / unclassified | — | Intramuscular |